Get the Stockscreener App
194.75
0.50%
0.97
After Hours:
194.84
0.09
+0.05%
Overview
News
Price History
Option Chain
Financials
Why DHR Down?
Discussions
Forecast
Stock Split
Dividend History
Danaher Corp stock is traded at $194.75, with a volume of 4.23M.
It is up +0.50% in the last 24 hours and down -0.24% over the past month.
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life sciences and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
See More
Previous Close:
$193.78
Open:
$194.58
24h Volume:
4.23M
Relative Volume:
1.03
Market Cap:
$137.82B
Revenue:
$24.57B
Net Income/Loss:
$3.60B
P/E Ratio:
38.56
EPS:
5.051
Net Cash Flow:
$5.26B
1W Performance:
+2.71%
1M Performance:
-0.24%
6M Performance:
-6.84%
1Y Performance:
+4.24%
1-Day Range:
$194.26
$197.02
1-Week Range:
$188.06
$200.40
52-Week Range:
$180.03
$242.80
Danaher Corp Stock (DHR) Company Profile
Name
Danaher Corp
Sector
Industry
Phone
(202) 828-0850
Address
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR vs TMO, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
194.75 | 137.82B | 24.57B | 3.60B | 5.26B | 5.051 |
TMO
Thermo Fisher Scientific Inc
|
526.60 | 195.70B | 44.56B | 6.72B | 6.29B | 17.74 |
IDXX
Idexx Laboratories Inc
|
589.25 | 46.80B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
121.87 | 34.44B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
327.77 | 32.18B | 3.17B | 642.63M | 516.49M | 10.77 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-02-25 | Initiated | Morgan Stanley | Overweight |
| Oct-08-25 | Downgrade | Rothschild & Co Redburn | Buy → Neutral |
| Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Apr-10-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Mar-21-25 | Upgrade | Goldman | Neutral → Buy |
| Mar-14-25 | Upgrade | Stifel | Hold → Buy |
| Feb-03-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-31-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-17-24 | Upgrade | HSBC Securities | Hold → Buy |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-18-23 | Initiated | HSBC Securities | Hold |
| Dec-13-23 | Resumed | Wolfe Research | Peer Perform |
| Dec-07-23 | Downgrade | Goldman | Buy → Neutral |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-01-23 | Initiated | SVB Securities | Outperform |
| Apr-26-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-18-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-05-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Oct-24-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Aug-17-22 | Resumed | Bernstein | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jun-01-22 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-11-22 | Initiated | Bernstein | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Sep-10-21 | Reiterated | BofA Securities | Buy |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-23-21 | Reiterated | Goldman | Buy |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Apr-07-21 | Resumed | Robert W. Baird | Outperform |
| Mar-03-21 | Resumed | Barclays | Overweight |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-16-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Apr-02-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-26-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-03-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Resumed | Stifel | Hold |
| Oct-28-19 | Reiterated | Needham | Buy |
| Oct-14-19 | Resumed | Credit Suisse | Outperform |
| Jul-19-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Piper Jaffray | Neutral |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| Apr-17-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Feb-25-19 | Upgrade | Janney | Neutral → Buy |
| Jan-03-19 | Initiated | Needham | Buy |
| Apr-20-18 | Reiterated | Stifel | Buy |
View All
Danaher Corp Stock (DHR) Latest News
Biotech Stocks To ConsiderApril 19th - MarketBeat
Dominion Energy Inc stock (US2358511028): Why mobile-first delivery is suddenly worth a closer look - AD HOC NEWS
Wealth Enhancement Trust Services Inc. Buys Shares of 14,087 Danaher Corporation $DHR - MarketBeat
Ninety One UK Ltd Sells 12,023 Shares of Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Bought by Merit Financial Group LLC - MarketBeat
Cwm LLC Purchases 9,542 Shares of Danaher Corporation $DHR - MarketBeat
Barclays and Evercore Stay Positive on Danaher (DHR) Despite Cutting Price Targets - Yahoo Finance
Best Biotech Stocks To ConsiderApril 18th - MarketBeat
How Danaher’s Expanded Infectious Disease Partnership Could Shape DHR’s Recurring Revenue Story - Yahoo Finance UK
Mirae Asset Global Investments Co. Ltd. Grows Holdings in Danaher Corporation $DHR - MarketBeat
Danaher Corporation (NYSE:DHR) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Danaher Corporation (DHR) Secures $5 Billion Revolving Credit Fa - GuruFocus
Saratoga Large Capitalization Value Portfolio's Danaher Corp(DHR) Holding History - GuruFocus
Top Biotech Stocks To Watch NowApril 17th - MarketBeat
Danaher Corporation $DHR Stake Lifted by Whittier Trust Co. - MarketBeat
DHR Maintained by Baird -- Price Target Lowered to $249 - GuruFocus
Danaher (NYSE: DHR) secures $5B 364-day revolving credit facility - Stock Titan
KBC Group NV Has $65.13 Million Stock Holdings in Danaher Corporation $DHR - MarketBeat
Lbp Am Sa Purchases 46,347 Shares of Danaher Corporation $DHR - MarketBeat
Fisher Funds Management LTD Has $91.23 Million Stock Position in Danaher Corporation $DHR - MarketBeat
Danaher Corp. stock outperforms competitors despite losses on the day - MarketWatch
Danaher Corporation (NYSE:DHR) Short Interest Up 25.0% in March - MarketBeat
Top Biotech Stocks To Watch TodayApril 16th - MarketBeat
Danaher Gears Up to Post Q1 Earnings: What Lies Ahead for the Stock? - Yahoo Finance
Chart of the Week: Danaher Stock Flashes Bullish Signals - Barron's
Ahead of Danaher (DHR) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Yahoo Finance
Greenwood Capital Associates LLC Has $5.01 Million Stake in Danaher Corporation $DHR - MarketBeat
Danaher Corporation $DHR Shares Sold by Border to Coast Pensions Partnership Ltd - MarketBeat
DHR Stock Price, Quote & Chart | DANAHER CORP (NYSE:DHR) - ChartMill
SeaBridge Investment Advisors LLC Takes Position in Danaher Corporation $DHR - MarketBeat
What to expect from Danaher Corporation's Q1 2026 earnings report - MSN
Danaher Corporation $DHR Shares Sold by Foster Victor Wealth Advisors LLC - MarketBeat
Danaher Corp. stock (US2358511028): Why does its business model matter more now for long-term invest - AD HOC NEWS
15,141 Shares in Danaher Corporation $DHR Purchased by Annex Advisory Services LLC - MarketBeat
Cepheid and Oxford Nanopore Expand Partnership Following Successful Phase One Collaboration - PR Newswire
Danaher Corp. stock (US2358511028): Is its life sciences moat strong enough to unlock new upside? - AD HOC NEWS
DHR Maintained by Barclays -- Price Target Lowered to $230 - GuruFocus
Danaher Corp. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Danaher (DHR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
TD Cowen Issues Pessimistic Forecast for Danaher (NYSE:DHR) Stock Price - MarketBeat
Norris Perne & French LLP MI Boosts Stake in Danaher Corporation $DHR - MarketBeat
JM2 Capital Inc. Takes $1.33 Million Position in Danaher Corporation $DHR - MarketBeat
Danaher (DHR) Projected to Post Earnings on Tuesday - MarketBeat
Danaher Corp (DHR) Stock Up 3.3% and Still Undervalued -- GF Sco - GuruFocus
Danaher Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
DHR Maintained by Goldman Sachs -- Price Target Lowered to $230 - GuruFocus
The Goldman Sachs Group Lowers Danaher (NYSE:DHR) Price Target to $230.00 - MarketBeat
What Is Danaher Corporation's (NYSE:DHR) Share Price Doing? - Yahoo Finance
Allergy Diagnostic Market by Product & Service, Test Type, Allergen, End User - GlobeNewswire Inc.
State of Alaska Department of Revenue Decreases Stock Holdings in Danaher Corporation $DHR - MarketBeat
Danaher Unit Receives CE Mark for Rapid Infection Test - marketscreener.com
Danaher Corp Stock (DHR) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):